Market Tracker

03/24 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

34.64
Delayed Data
As of Mar 24
 -0.07 / -0.20%
Today’s Change
21.11
Today|||52-Week Range
35.61
+12.39%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close34.71
Today’s open34.80
Day’s range34.14 - 34.91
Volume200,546
Average volume (3 months)234,289
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+25.57%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+25.14%
P/E ratio101.9
Price/Sales10.05
Price/Book6.95

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.46+1.62%
ACORAcorda Therapeutics ...0.000.00%
LOXOLoxo Oncology Inc+1.01+2.27%
AIMTAimmune Therapeutics...+0.04+0.18%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts